At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TAP) Block in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study
In Brief
A clinical study evaluating Placebo and (study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side. for Pain and 2 related conditions. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The use of preoperative TAP block in laparoscopic bariatric surgery can improve the postoperative pain and quality of recovery in patients undergoing these procedures.
Study Details
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2010
Enrollment StartMar 2010
Primary CompletionJul 2012
Study CompletionAug 2012
TodayJul 2026
First PostedFeb 24, 2010
Enrollment StartMar 1, 2010
Primary CompletionJul 1, 2012
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 16.4 years ago
Interventions
Placebodrug
Bilateral TAP block using sterile normal saline.
(study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side.drug
(study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side.